229 related articles for article (PubMed ID: 20889561)
21. Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice.
Amritraj A; Peake K; Kodam A; Salio C; Merighi A; Vance JE; Kar S
Am J Pathol; 2009 Dec; 175(6):2540-56. PubMed ID: 19893049
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.
Rodriguez-Franco EJ; Cantres-Rosario YM; Plaud-Valentin M; Romeu R; Rodríguez Y; Skolasky R; Meléndez V; Cadilla CL; Melendez LM
PLoS One; 2012; 7(5):e36571. PubMed ID: 22693552
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotection mediated by cystatin C-loaded extracellular vesicles.
Pérez-González R; Sahoo S; Gauthier SA; Kim Y; Li M; Kumar A; Pawlik M; Benussi L; Ghidoni R; Levy E
Sci Rep; 2019 Jul; 9(1):11104. PubMed ID: 31367000
[TBL] [Abstract][Full Text] [Related]
24. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy.
Suzuki Y; Jin C; Yazawa I
Am J Pathol; 2014 Mar; 184(3):790-9. PubMed ID: 24405769
[TBL] [Abstract][Full Text] [Related]
25. Cystatin B and its EPM1 mutants are polymeric and aggregate prone in vivo.
Cipollini E; Riccio M; Di Giaimo R; Dal Piaz F; Pulice G; Catania S; Caldarelli I; Dembic M; Santi S; Melli M
Biochim Biophys Acta; 2008 Feb; 1783(2):312-22. PubMed ID: 17920138
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
Wang C; Sun B; Zhou Y; Grubb A; Gan L
J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
[TBL] [Abstract][Full Text] [Related]
27. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy.
Rinne R; Saukko P; Järvinen M; Lehesjoki AE
Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481
[TBL] [Abstract][Full Text] [Related]
28. New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B.
Di Giaimo R; Riccio M; Santi S; Galeotti C; Ambrosetti DC; Melli M
Hum Mol Genet; 2002 Nov; 11(23):2941-50. PubMed ID: 12393805
[TBL] [Abstract][Full Text] [Related]
29. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.
Laurent-Matha V; Huesgen PF; Masson O; Derocq D; Prébois C; Gary-Bobo M; Lecaille F; Rebière B; Meurice G; Oréar C; Hollingsworth RE; Abrahamson M; Lalmanach G; Overall CM; Liaudet-Coopman E
FASEB J; 2012 Dec; 26(12):5172-81. PubMed ID: 22898924
[TBL] [Abstract][Full Text] [Related]
30. White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice.
Manninen O; Koskenkorva P; Lehtimäki KK; Hyppönen J; Könönen M; Laitinen T; Kalimo H; Kopra O; Kälviäinen R; Gröhn O; Lehesjoki AE; Vanninen R
Radiology; 2013 Oct; 269(1):232-9. PubMed ID: 23788720
[TBL] [Abstract][Full Text] [Related]
31. CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy.
Gumusgoz E; Kasiri S; Verma M; Wu J; Villarreal Acha D; Marriam U; Fyffe-Maricich S; Lin A; Chen X; Gray SJ; Minassian BA
Gene Ther; 2024 May; 31(5-6):234-241. PubMed ID: 38135787
[TBL] [Abstract][Full Text] [Related]
32. Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1).
Riccio M; Di Giaimo R; Pianetti S; Palmieri PP; Melli M; Santi S
Exp Cell Res; 2001 Jan; 262(2):84-94. PubMed ID: 11139332
[TBL] [Abstract][Full Text] [Related]
33. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
Pennacchio LA; Bouley DM; Higgins KM; Scott MP; Noebels JL; Myers RM
Nat Genet; 1998 Nov; 20(3):251-8. PubMed ID: 9806543
[TBL] [Abstract][Full Text] [Related]
34. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
Yamada M; Shimohata M; Sato T; Tsuji S; Takahashi H
Neuropathology; 2006 Aug; 26(4):346-51. PubMed ID: 16961072
[TBL] [Abstract][Full Text] [Related]
35. Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy.
Arbatova J; D'Amato E; Vaarmann A; Zharkovsky A; Reeben M
Epilepsia; 2005; 46 Suppl 5():49-51. PubMed ID: 15987253
[TBL] [Abstract][Full Text] [Related]
36. rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C.
Ahuja S; Ahuja-Jensen P; Johnson LE; Caffé AR; Abrahamson M; Ekström PA; van Veen T
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1089-96. PubMed ID: 18326735
[TBL] [Abstract][Full Text] [Related]
37. HIV-infected microglia mediate cathepsin B-induced neurotoxicity.
Zenón F; Cantres-Rosario Y; Adiga R; Gonzalez M; Rodriguez-Franco E; Langford D; Melendez LM
J Neurovirol; 2015 Oct; 21(5):544-58. PubMed ID: 26092112
[TBL] [Abstract][Full Text] [Related]
38. Seizures, ataxia, and neuronal loss in cystatin B heterozygous mice.
Kaasik A; Kuum M; Aonurm A; Kalda A; Vaarmann A; Zharkovsky A
Epilepsia; 2007 Apr; 48(4):752-7. PubMed ID: 17319918
[TBL] [Abstract][Full Text] [Related]
39. Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1-linked amyotrophic lateral sclerosis mice.
Watanabe S; Komine O; Endo F; Wakasugi K; Yamanaka K
J Neurochem; 2018 Apr; 145(1):80-89. PubMed ID: 29282717
[TBL] [Abstract][Full Text] [Related]
40. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.
Vaarmann A; Kaasik A; Zharkovsky A
Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
